GBA: we have two lots and an average C/B of $172. GBA SELL--->AAPL Apple Inc. $172--------->$215****** Consecutive win No 58 $215.48 +8.33 (+4.02%)10:46 AM 06/12/24 NASDAQ | $USD | Realtime
I was up $800 on GME, tested the waters. Pounded the Apple $210 and Orcl $140c, fun trades. Flipped 12000 DDC $1.48 out $1.75.
Everything I try takes forever . People need new under garments c'mon buy buy UA Under Armour Inc $6.80 2.48%
Thank you! I like how GSCO tried to kill the momentum and it takes out the 52 week! Don’t mess with Lizard God!
With Bio sometimes you buy the event. Not the product./ Little scared but here is where I would go with ANVS- $6.50 So we know the recent news has not been god this is a " save " situation for management. Can they hype this? I would bet yes./// But still this is highly shorted. And I don't think they cpuld say anything that would really dislodge the shorts. MALVERN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis, Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap. Investor Call Details: Date and Time: June 11, 2024, 4:30pm ET. Topics to Be Covered: Recent advancements in the development of Buntanetap. Strategic plans for upcoming clinical trials. Overview of the company’s progress and future direction.